Dr. Swapnil Vaidya, MD, PhD

Dr. Vaidya practices at Advanced Allergy & Asthma Associates in Fort Worth, Texas.

Dr. Vaidya's NPI, 1457575615, was assigned on April 12, 2007. Dr. Vaidya graduated from Government Medical College Nagpur in 1999. Dr. Vaidya's Texas license number on file is P0805.

Dr. Vaidya's primary practice is Advanced Allergy & Asthma Associates, at 9433 N Beach St Ste 111 Suite 111, Fort Worth, TX 76244. The practice phone is (817) 428-7000.

Dr. Vaidya's primary practice is Advanced Allergy & Asthma Associates in Fort Worth, Texas. The medical group on file is Advanced Allergy & Asthma Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaidya practices. Vendor and product names are available with a free account.

Allergy is Dr. Vaidya's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Vaidya is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Vaidya's licenses on file in 2 states: Texas and California.

Dmand AI lists asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Vaidya treats.

CMS data shows 5,490 Medicare services from Dr. Vaidya across 10 procedure codes in 2024, for 105 Medicare patients. Medicare paid $49,398 for them. Every service was in an office.

CMS counts 105 Medicare patients who saw Dr. Vaidya in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vaidya's median patient age at 46, with 59% women.

In 2024, Dr. Vaidya wrote 330 Medicare Part D claims for 85 patients. 62% of them were for generic drugs. CMS names the drug for 250 of them, across 9 drugs with 11 or more claims each, at $145,856 in total drug cost. In 2023, CMS named 186 claims across 9 drugs.

Dr. Vaidya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Vaidya, published from 2005 to 2025. 2012 was the busiest year, with 3. The most frequent topics are Receptors, Immunologic, Signaling Lymphocytic Activation Molecule Family and Antigens, CD. Dr. Vaidya has published most often in Indian J Orthop. Dr. Vaidya's most frequent co-authors are Nilesh Dharajiya, MD, MBBS, Stephen T. Mathew, MD and Sanjiv Sur, MD.

Dmand AI links Dr. Vaidya to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Dermatitis, Atopic, Eczema and Skin Diseases, Eczematous. Asana BioSciences sponsors the most, 2. Open Payments lists research payments to Dr. Vaidya that name 1 trial.

CMS Open Payments shows 371 general payments to Dr. Vaidya from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,780. It also lists 3 research payments totaling $1,591 in 2017, naming 1 clinical trial.

Dr. Vaidya graduated from Government Medical College Nagpur in 1999.

Dr. Vaidya is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.